On Friday the 24th of August was launched the new Ethical Standards in Health and Life Sciences Group (ESHLSG) website (www.eshlsg.org).

The group’s aim is to “evolve the relationship between health professionals and commercial life science organisations to ensure that it meets the expectations of stakeholders and creates a platform for increased collaboration and partnership for the benefit of patients“.

The multi-stakeholder group consists of 16 healthcare organisations, with representation from the medical community and the pharmaceutical, medical device and diagnostic industries in the UK. The ESHLSG was established to address the partnership issues that can impact on the relationship between commercial organisations and health professionals, and ensure that the relationship meets the high expectations of all stakeholders, and patients in particular.

ESHLSG has already published a guidance on collaboration between healthcare professionals and the pharmaceutical industry (found here) and one on the transparency of clinical trials (here).

One of the main topics to be addressed by the group from September 2012 to the beginning of 2013 is the support to set-up for a system of public declaration of payments to health professionals. Indeed from January 2013, commercial life science companies (pharmaceutical, medical device and diagnostics) have to publicly display their financial relationships with health professionals. In the autumn of 2012, the ESHLSG will be consulting across the healthcare professional community and the life sciences industry to understand individuals’ and organisations’ views on the public disclosure of payments to health professionals.

Source: ABPI website, ESHLSG website